Home
About
Publications Trends
Recent Publications
Expert Search
Archive
venous thromboembolism (vte)
What is Venous Thromboembolism?
Venous Thromboembolism (VTE)
refers to a condition that includes both
deep vein thrombosis (DVT)
and
pulmonary embolism (PE)
. DVT involves the formation of blood clots in deep veins, typically in the legs, while PE occurs when these clots travel to the lungs, potentially leading to fatal complications.
Frequently asked queries:
What is Venous Thromboembolism?
Why is VTE Common in Cancer Patients?
What Types of Cancer are Most Associated with VTE?
How is VTE Diagnosed in Cancer Patients?
What are the Symptoms of VTE?
How is VTE Treated in Cancer Patients?
What are the Preventive Measures for VTE in Cancer Patients?
What is the Prognosis for Cancer Patients with VTE?
What is the Prognosis for Patients with HHM?
What are Bronchodilators?
What Are the Risks of SQL Injection in Cancer Databases?
What is Sonography?
What is the Prognosis for AML?
Does Age Affect Cancer Survival Rates?
What Are the Obstacles in Personalized Medicine?
What is Excavator2?
How Effective is the Influenza Vaccine in Cancer Patients?
Can Tumor Cells Be Detected Early?
What were the Results?
What Are the Ethical Considerations Related to Transparency?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe